Human Growth Hormone Market 2017 Global Analysis • F. Hoffmann-La Roche, Merck Serono, Novo Nordisk Forecast to 2019

For Immediate Release

Human Growth Hormone Market in the US 2015-2019

Press Release: Pune, India- 6th July , 2017

Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual. The effects of human growth hormone are mainly mediated by IGF-1 and IGF-2. There are two forms of recombinant human growth hormone approved in the market: Somatropin and Somatrem. Somatropin has 191 amino acids and Somatrem contains 192 amino acids. Growth hormone deficiency can occur either due to a damage to the pituitary or the hypothalamus gland, or can also be acquired genetically. Some of the signs of growth hormone deficiency are adiposity, short stature, and hypoglycemia.

TechNavio’s analysts forecast the Human Growth Hormone market in the US to grow at a CAGR of 3.86 percent over the period 2014-2019.


This report covers the present scenario and the growth prospects of the Human Growth Hormone market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of the various human growth hormone drugs available in the US for the treatment of growth hormone deficiency.

TechNavio’s report, the Human Growth Hormone Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Human Growth Hormone market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Vendors
• F. Hoffmann-La Roche
• Merck Serono
• Novo Nordisk
• Pfizer

Other Prominent Vendors
• Eli Lilly
• Teva Pharmaceutical
• Novartis
• Ipsen

For Sample Report  @

Market Driver
• Demand for Human Growth Hormone
• For a full, detailed list, view our report

Market Challenge
• High Cost of Therapy
• For a full, detailed list, view our report

Market Trend
• Growing Focus on Needle-free Drug Delivery Devices
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 For any Enquiry write us @

Table of Content

  1. Executive Summary
    02. List of Abbreviations
    03. Scope of the Report
    03.1 Market Overview
    03.2 Product Offerings
    04. Market Research Methodology
    04.1 Market Research Process
    04.2 Research Methodology
    05. Introduction
    06. Human Growth Hormone: An Overview
        06.1 Human Growth Hormone
    06.2 Pharmacological Action of Human Growth Hormone
    06.3 Therapeutic Uses of Human Growth Hormone
    06.4 Growth Hormone Deficiency
    06.4.1 Childhood-onset Growth Hormone Deficiency
    06.4.2 Adult-onset Growth Hormone Deficiency
    07. Market Landscape
        07.1 Market Overview
    07.2 Market Size and Forecast
    07.3 Five Forces Analysis
    08. Buying Criteria
    09. Market Growth Drivers

    10. Drivers and their Impact
    11. Market Challenges
    12. Impact of Drivers and Challenges
    13. Market Trends
    14. Trends and their Impact
    15. Vendor Landscape
        15.1 Competitive Scenario
    15.1.1 Key News
    15.1.2 Mergers and Acquisitions
    15.2 Market Share Analysis 2014
    15.2.1 Novo Nordisk
    15.2.2 Pfizer
    15.2.3 Merck Serono
    15.2.4 F. Hoffmann-La Roche
    15.3 Other Prominent Vendors
    16. Key Vendor Analysis
    16.1 F. Hoffmann-La Roche Ltd.
    16.1.1 Key Facts
    16.1.2 Business Overview
    16.1.3 Business Segmentation
    16.1.4 Business Segmentation by Revenue 2012 and 2013
    16.1.5 Sales by Geography
    16.1.6 Business Strategy
    16.1.7 Key Information
    16.1.8 SWOT Analysis
    16.2 Merck Serono
    16.2.1 Key Facts
    16.2.2 Business Overview
    16.2.3 Geographical Segmentation by Revenue 2013
    16.2.4 Business Strategy
    16.2.5 Recent Developments
    16.2.6 SWOT Analysis
    16.3 Novo Nordisk A/S
    16.3.1 Key Facts
    16.3.2 Business Overview
    16.3.3 Business Segmentation by Revenue 2013
    16.3.4 Business Segmentation by Revenue 2012 and 2013
    16.3.5 Sales by Geography
    16.3.6 Business Strategy
    16.3.7 Key Information
    16.3.8 SWOT Analysis
    16.4 Pfizer
    16.4.1 Key Facts
    16.4.2 Business Overview
    16.4.3 Business Segmentation by Revenue 2013
    16.4.4 Business Segmentation by Revenue 2012 and 2013
    16.4.5 Geographical Segmentation by Revenue
    16.4.6 Business Strategy
    16.4.7 Key Developments
    16.4.8 SWOT Analysis
    17. Other Reports in this Series


For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check :

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check :


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s